Second intron of mouse nestin gene directs its expression in pluripotent embryonic carcinoma cells through POU factor binding site

Acta Biochimica Et Biophysica Sinica
Zhi-Gang JinNai-He Jing

Abstract

Nestin, an intermediate filament protein, is expressed in the neural stem cells of the developing central nervous system. This tissue-specific expression is driven by the neural stem cell-specific enhancer in the second intron of the nestin gene. In this study, we showed that the mouse nestin gene was expressed in pluripotent embryonic carcinoma (EC) P19 and F9 cells, not in the differentiated cell types. This cell type-specific expression was conferred by the enhancer in the second intron. Mutation of the conserved POU factor-binding site in the enhancer abolished the reporter gene expression in EC cells. Oct4, a Class V POU factor, was found to be coexpressed with nestin in EC cells. Electrophoretic mobility-shift assays and supershift assays showed that a unique protein-DNA complex was formed specifically with nuclear extracts of EC cells, and Oct4 protein was included. Together, these results suggest the functional relevance between the conserved POU factor-binding site and the expression of the nestin gene in pluripotent EC cells.

References

Jun 8, 2000·Mechanisms of Development·J YangN Jing
Feb 17, 2001·Molecular and Cellular Neurosciences·A KawaguchiH Okano
Jan 20, 2004·The Journal of Comparative Neurology·John L MignoneGrigori Enikolopov
May 12, 2004·FEBS Letters·Leping ChengNaihe Jing
Jul 21, 2004·The Journal of Biological Chemistry·Raffaella CatenaSilvia K Nicolis
Oct 1, 2004·Molecular and Cellular Biology·Shinya TanakaHisato Kondoh

❮ Previous
Next ❯

Citations

Nov 3, 2010·Behavior Genetics·Haiying MengJeffrey R Gruen
Nov 13, 2012·Stem Cells and Development·Jean-Luc BoullandPhilippe Collas
Jun 7, 2008·Acta Biochimica Et Biophysica Sinica·Hua ZhongNaihe Jing
Aug 29, 2014·Cellular Oncology (Dordrecht)·Ekaterini Christina TampakiGregory Kouraklis
May 6, 2009·Stem Cells·Dong Wook HanHans R Schöler
May 18, 2011·Nucleic Acids Research·Stefan BroosPieter De Bleser
Apr 5, 2013·Molecular Cancer Research : MCR·Huei-Ting SuKuang-Hung Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.